BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18635721)

  • 1. [Not Available].
    Elefante RJO; Lu C; Bach PJ
    CMAJ; 2024 May; 196(19):E687-E688. PubMed ID: 38772611
    [No Abstract]   [Full Text] [Related]  

  • 2. WITHDRAWN: Antidepressants for generalised anxiety disorder (GAD).
    Kapczinski F; dos Santos Souza JJ; Batista Miralha da Cunha AA; Schmitt RR
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD003592. PubMed ID: 26963371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trials in psychiatry: important but poorly accepted.
    Andrews G
    BMJ; 1999 Aug; 319(7209):562-4. PubMed ID: 10463902
    [No Abstract]   [Full Text] [Related]  

  • 4. Trauma-focused psychodynamic therapy and STAIR Narrative Therapy of post-traumatic stress disorder related to childhood maltreatment: trial protocol of a multicentre randomised controlled trial assessing psychological, neurobiological and health economic outcomes (ENHANCE).
    Leichsenring F; Steinert C; Beutel ME; Feix L; Gündel H; Hermann A; Karabatsiakis A; Knaevelsrud C; König HH; Kolassa IT; Kruse J; Niemeyer H; Nöske F; Palmer S; Peters E; Reese JP; Reuss A; Salzer S; Schade-Brittinger C; Schuster P; Stark R; Weidner K; von Wietersheim J; Witthöft M; Wöller W; Hoyer J
    BMJ Open; 2020 Dec; 10(12):e040123. PubMed ID: 33334832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized noninferiority trial evaluating remotely-delivered stepped care for depression using internet cognitive behavioral therapy (CBT) and telephone CBT.
    Mohr DC; Lattie EG; Tomasino KN; Kwasny MJ; Kaiser SM; Gray EL; Alam N; Jordan N; Schueller SM
    Behav Res Ther; 2019 Dec; 123():103485. PubMed ID: 31634738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Escitalopram versus Electric Current Therapy for Treating Depression Clinical Study (ELECT-TDCS): rationale and study design of a non-inferiority, triple-arm, placebo-controlled clinical trial.
    Brunoni AR; Sampaio-Junior B; Moffa AH; Borrione L; Nogueira BS; Aparício LV; Veronezi B; Moreno M; Fernandes RA; Tavares D; Bueno PV; Seibt O; Bikson M; Fraguas R; Benseñor IM
    Sao Paulo Med J; 2015; 133(3):252-63. PubMed ID: 26176930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials.
    Kasper S
    Wien Med Wochenschr; 2015 Jun; 165(11-12):217-28. PubMed ID: 26092515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telephone cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a randomized controlled non-inferiority trial.
    Turner CM; Mataix-Cols D; Lovell K; Krebs G; Lang K; Byford S; Heyman I
    J Am Acad Child Adolesc Psychiatry; 2014 Dec; 53(12):1298-1307.e2. PubMed ID: 25457928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: a randomized trial.
    Mohr DC; Ho J; Duffecy J; Reifler D; Sokol L; Burns MN; Jin L; Siddique J
    JAMA; 2012 Jun; 307(21):2278-85. PubMed ID: 22706833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.
    Tambaro S; Bortolato M
    Recent Pat CNS Drug Discov; 2012 Apr; 7(1):25-40. PubMed ID: 22280339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification.
    Madlung-Kratzer E; Spitzer B; Brosch R; Dunkel D; Haring C
    Addiction; 2009 Sep; 104(9):1549-57. PubMed ID: 19686525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.
    Hartford J; Kornstein S; Liebowitz M; Pigott T; Russell J; Detke M; Walker D; Ball S; Dunayevich E; Dinkel J; Erickson J
    Int Clin Psychopharmacol; 2007 May; 22(3):167-74. PubMed ID: 17414743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract]   [Full Text] [Related]  

  • 14. Wine and drug evaluations: lessons on making comparisons of noninferiority.
    Allgulander C; Nutt D
    J Psychopharmacol; 2008 Jun; 22(4):341-2. PubMed ID: 18635714
    [No Abstract]   [Full Text] [Related]  

  • 15. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
    Stahl SM; Grady MM; Moret C; Briley M
    CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting.
    Nutt D; Allgulander C; Lecrubier Y; Peters T; Wittchen U
    J Psychopharmacol; 2008 Jun; 22(4):409-16. PubMed ID: 18635721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.
    Allgulander C; Nutt D; Detke M; Erickson J; Spann M; Walker D; Ball S; Russell J
    J Psychopharmacol; 2008 Jun; 22(4):417-25. PubMed ID: 18635722
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.